Atlas Venture Associates XI, 10% Owner: Xilio Therapeutics XLO Sell · Filed 24/01/16

Trade details

Type: Insider sale
Amount: $1,362.42
Shares · price: 1,566 sh · $0.87 a share
Held after: 2,021,836 sh
Stock: Xilio Therapeutics XLO
Person: Atlas Venture Associates XI10% Owner
Trade date: 24/01/11
Filed: 24/01/16
Days to filing: 5 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Xilio Therapeutics trades, last 26 weeks

What else happened in Xilio Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/12~24/02/10

Atlas Venture Associates XI's recent trades

Atlas Venture Associates XIShareholder
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$114.2K
5,000 sh
$114.2K
Filed 07/07
Traded 07/07
Atlas Venture Associates XIShareholder
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 plan
Dyne Therapeutics
DYN
$7,477
428 sh
$7,477
Filed 05/06
Traded 05/06
Atlas Venture Associates XIShareholder
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 plan
Dyne Therapeutics
DYN
$1,063
60 sh
$1,063
Filed 05/05
Traded 05/05
Atlas Venture Associates XIShareholder
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 plan
Dyne Therapeutics
DYN
$1,061
61 sh
$1,061
Filed 05/04
Traded 04/29
Atlas Venture Associates XIShareholder
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 plan
Dyne Therapeutics
DYN
$21.1K
1,171 sh
$21.1K
Filed 04/28
Traded 04/28